FTC sues main pharmacy profit administrators above insulin charges The company introduced motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of lifestyle-conserving insulin medicine. Insurers will go on vertically integrating to maintain extra earnings in-property, and federal scru... https://rafaelwnevk.blogdun.com/31237427/considerations-to-know-about-healthcare-news